New injection HEC-007 tested for safety in first human trial
NCT ID NCT07102251
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests the safety and how the body handles a new injection called HEC-007. It involves 126 healthy adults and overweight or obese individuals. Researchers will monitor side effects, measure drug levels in the blood, and check changes in weight and other health markers. The goal is to gather initial safety data before larger studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Anhui Medical University is a Grade A Tertiary General
RECRUITINGHefei, Anhui, 230601, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive tracer reveals the Body's journey of an experimental drug
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?